The Australian experience with switching to extended half-life factor VIII and IX concentrates: On behalf of the Australian Haemophilia Centre Directors' Organisation.
Yvonne BrennanSumit ParikhSimon McRaeHuyen TranPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2020)
Compared to SHL, EHL FVIII resulted in improved bleeding outcomes, albeit at the expense of increased factor utilization. EHL FIX resulted in improved bleeding outcomes despite decreased factor utilization.